Clinical Gastroenterology and Hepatology
Volume 3, Issue 9 , Pages 852-858, September 2005

Increased Liver Chemistry in an Asymptomatic Patient

  • Wolfram Goessling

      Affiliations

    • Harvard Medical School, Boston, Massachusetts
    • Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts
    • Medical Oncology, Dana-Farber Cancer Institute and Brigham and Women’s Hospital, Boston, Massachusetts
    • Hematology/Oncology, Children’s Hospital, Boston, Massachusetts
  • ,
  • Lawrence S. Friedman

      Affiliations

    • Harvard Medical School, Boston, Massachusetts
    • Gastrointestinal Unit, Massachusetts General Hospital, Boston, Massachusetts
    • Department of Medicine, Newton-Wellesley Hospital, Newton, Massachusetts
    • Corresponding Author InformationAddress requests for reprints to: Lawrence S. Friedman, MD, Chair, Department of Medicine, Newton-Wellesley Hospital, 2014 Washington Street, Newton, Massachusetts 02462. fax: (617) 243-6701.

published online 22 July 2005.

A 38-year-old real estate agent presents to the office for evaluation of abnormal liver test results that were noticed when he underwent testing for a new life insurance policy. The patient has no complaints, exercises regularly, and takes no medications. He is married, has 2 young children, and does not smoke. He rarely drinks alcohol. His physical examination reveals no abnormalities. His body mass index is 24 kg/m2. Laboratory evaluation shows an alanine transaminase level of 76 U/L (normal, 10–40 U/L), an aspartate transaminase level of 53 U/L (normal, 10–40 U/L), an alkaline phosphatase level of 110 U/L (normal, 25–100 U/L), an albumin level of 4.3 g/dL, and a total bilirubin level of .7 mg/dL. A complete blood count and coagulation parameters are normal. Retesting 1 month later shows an alanine transaminase level of 71 U/L and an aspartate transaminase level of 50 U/L.

Abbreviations used in this paper:  ALT, alanine transaminase , AST, aspartate transaminase , CT, computed tomography , NAFLD, nonalcoholic fatty liver disease

 

PII: S1542-3565(05)00416-7

Clinical Gastroenterology and Hepatology
Volume 3, Issue 9 , Pages 852-858, September 2005